Comment on

• Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.

  Inciarte-Mundo J, Victoria Hernández M, Ruiz-Esquide V, Raquel Cabrera-Villalba S, Ramirez J, Cuervo A, Pascal M, Yagüe J, Cañete JD, Sanmarti R. Inciarte-Mundo J, et al. Arthritis Care Res (Hoboken). 2016 Jul;68(7):899-906. doi: 10.1002/acr.22795. Arthritis Care Res (Hoboken). 2016. PMID: 26841119
• Equivalent Units of Serum C-Reactive Protein and Calprotectin are Compared in a Recent RA Study: Comment on the Article by Inciarte-Mundo et al.

  Masi AT, Jorgenson L, Freels S. Masi AT, et al. Arthritis Care Res (Hoboken). 2017 Apr;69(4):605-606. doi: 10.1002/acr.23126. Epub 2017 Mar 3. Arthritis Care Res (Hoboken). 2017. PMID: 27748059 No abstract available.